The Inherent Unfairness of COVID-19 Drug Access Pathways
Am J Bioeth
.
2020;20(9):18-20.
doi: 10.1080/15265161.2020.1795546.
Epub 2020 Aug 25.
Authors
Kayte Spector-Bagdady
1
,
Misty Gravelin
2
,
Kevin J Weatherwax
2
,
Andrew G Shuman
1
Affiliations
1
Center for Bioethics & Social Sciences in Medicine, University of Michigan Medical School.
2
Michigan Institute for Clinical & Health Research, University of Michigan Medical School.
PMID:
33505223
PMCID:
PMC7837294
DOI:
10.1080/15265161.2020.1795546
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Employment
Humans
Interpersonal Relations
Pharmaceutical Preparations*
SARS-CoV-2
Substances
Pharmaceutical Preparations
Grants and funding
U01 TR002488/TR/NCATS NIH HHS/United States
UL1 TR002240/TR/NCATS NIH HHS/United States